This document outlines a roadmap for developing molecular diagnostics in the Netherlands. It discusses the need to integrate biomarker discovery with diagnostic test development and clinical application. The goal is to define a framework that facilitates moving candidate biomarkers through validation and regulatory approval to reimbursed clinical use. This will help address unmet medical needs through improved personalized healthcare.